aluates Reports

$ 0.0

Automative

Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-25O18590

BUY CHAPTERS

Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-25O18590

Report

December 2024

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Allergan plc

Bristol–Myers Squibb

GSK

Janssen

AbbVie

Youdim

Delpor

Lundbeck

Intra-Cellular Therapies

Novartis Pharmaceuticals Corporation

Noven Pharmaceuticals

Otsuka

Pfizer Inc

Reviva Pharmaceuticals

Bipolar Disorder Therapeutics Drugs Market

Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients' quality of life and maintain good social function as much as possible.

The global Bipolar Disorder Therapeutics Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bipolar Disorder Therapeutics Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Bipolar Disorder Therapeutics Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Bipolar Disorder Therapeutics Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Bipolar Disorder Therapeutics Drugs include AstraZeneca, Allergan, Bristol-Myers Squibb, GSK, Janssen, AbbVie, Youdim, Delpor and Lundbeck, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Bipolar Disorder Therapeutics Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Bipolar Disorder Therapeutics Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bipolar Disorder Therapeutics Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bipolar Disorder Therapeutics Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Bipolar Disorder Therapeutics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Bipolar Disorder Therapeutics Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Bipolar Disorder Therapeutics Drugs Market Report

Report Metric	Details
Report Name	Bipolar Disorder Therapeutics Drugs Market
Segment by Type	Olanzapine (Zyprexa) Quetiapine (Seroquel) Risperidone (Risperdal) Ariprazole (Abilify) Ziprasidone (Geodon) Clozapine (Clozaril)
Segment by Application	lumateperone Central Nervous System (CNS) Disorders
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, GSK, Janssen, AbbVie, Youdim, Delpor, Lundbeck, Intra-Cellular Therapies, Novartis Pharmaceuticals Corporation, Noven Pharmaceuticals, Otsuka, Pfizer, Reviva Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bipolar Disorder Therapeutics Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bipolar Disorder Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bipolar Disorder Therapeutics Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bipolar Disorder Therapeutics Drugs Market report?

Ans: The main players in the Bipolar Disorder Therapeutics Drugs Market are Bristol-Myers Squibb, GSK, Janssen, AbbVie, Youdim, Delpor, Lundbeck, Intra-Cellular Therapies, Novartis Pharmaceuticals Corporation, Noven Pharmaceuticals, Otsuka, Pfizer, Reviva Pharmaceuticals

What are the Application segmentation covered in the Bipolar Disorder Therapeutics Drugs Market report?

Ans: The Applications covered in the Bipolar Disorder Therapeutics Drugs Market report are lumateperone, Central Nervous System (CNS) Disorders

What are the Type segmentation covered in the Bipolar Disorder Therapeutics Drugs Market report?

Ans: The Types covered in the Bipolar Disorder Therapeutics Drugs Market report are Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Ariprazole (Abilify), Ziprasidone (Geodon), Clozapine (Clozaril)

Recommended Reports

Mood Disorder Treatments

Neurological Disorder Drugs

Other Disease Therapeutics

1 Study Coverage

1.1 Bipolar Disorder Therapeutics Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Olanzapine (Zyprexa)

1.2.3 Quetiapine (Seroquel)

1.2.4 Risperidone (Risperdal)

1.2.5 Ariprazole (Abilify)

1.2.6 Ziprasidone (Geodon)

1.2.7 Clozapine (Clozaril)

1.3 Market by Application

1.3.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 lumateperone

1.3.3 Central Nervous System (CNS) Disorders

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Bipolar Disorder Therapeutics Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Region

2.2.1 Global Bipolar Disorder Therapeutics Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2019-2024)

2.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2025-2030)

2.2.4 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Bipolar Disorder Therapeutics Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Bipolar Disorder Therapeutics Drugs Sales by Region

2.4.1 Global Bipolar Disorder Therapeutics Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Bipolar Disorder Therapeutics Drugs Sales by Region (2019-2024)

2.4.3 Global Bipolar Disorder Therapeutics Drugs Sales by Region (2025-2030)

2.4.4 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers

3.1.1 Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bipolar Disorder Therapeutics Drugs in 2023

3.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers

3.2.1 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutics Drugs Revenue in 2023

3.3 Global Key Players of Bipolar Disorder Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Bipolar Disorder Therapeutics Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type

4.1.1 Global Bipolar Disorder Therapeutics Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

4.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type

4.2.1 Global Bipolar Disorder Therapeutics Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Bipolar Disorder Therapeutics Drugs Price by Type

4.3.1 Global Bipolar Disorder Therapeutics Drugs Price by Type (2019-2024)

4.3.2 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Bipolar Disorder Therapeutics Drugs Sales by Application

5.1.1 Global Bipolar Disorder Therapeutics Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

5.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Application

5.2.1 Global Bipolar Disorder Therapeutics Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Bipolar Disorder Therapeutics Drugs Price by Application

5.3.1 Global Bipolar Disorder Therapeutics Drugs Price by Application (2019-2024)

5.3.2 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Bipolar Disorder Therapeutics Drugs Market Size by Type

6.1.1 US & Canada Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2030)

6.2 US & Canada Bipolar Disorder Therapeutics Drugs Market Size by Application

6.2.1 US & Canada Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2030)

6.3 US & Canada Bipolar Disorder Therapeutics Drugs Market Size by Country

6.3.1 US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Bipolar Disorder Therapeutics Drugs Market Size by Type

7.1.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2030)

7.1.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2030)

7.2 Europe Bipolar Disorder Therapeutics Drugs Market Size by Application

7.2.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2030)

7.2.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2030)

7.3 Europe Bipolar Disorder Therapeutics Drugs Market Size by Country

7.3.1 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2030)

7.3.3 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Bipolar Disorder Therapeutics Drugs Market Size

8.1.1 China Bipolar Disorder Therapeutics Drugs Sales (2019-2030)

8.1.2 China Bipolar Disorder Therapeutics Drugs Revenue (2019-2030)

8.2 China Bipolar Disorder Therapeutics Drugs Market Size by Application

8.2.1 China Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2030)

8.2.2 China Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Bipolar Disorder Therapeutics Drugs Market Size by Type

9.1.1 Asia Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2030)

9.1.2 Asia Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2030)

9.2 Asia Bipolar Disorder Therapeutics Drugs Market Size by Application

9.2.1 Asia Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2030)

9.2.2 Asia Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2030)

9.3 Asia Bipolar Disorder Therapeutics Drugs Sales by Region

9.3.1 Asia Bipolar Disorder Therapeutics Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Bipolar Disorder Therapeutics Drugs Revenue by Region (2019-2030)

9.3.3 Asia Bipolar Disorder Therapeutics Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Information

11.1.2 AstraZeneca Overview

11.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AstraZeneca Recent Developments

11.2 Allergan

11.2.1 Allergan Company Information

11.2.2 Allergan Overview

11.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Allergan Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Allergan Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Information

11.3.2 Bristol-Myers Squibb Overview

11.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 GSK

11.4.1 GSK Company Information

11.4.2 GSK Overview

11.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 GSK Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 GSK Recent Developments

11.5 Janssen

11.5.1 Janssen Company Information

11.5.2 Janssen Overview

11.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Janssen Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Janssen Recent Developments

11.6 AbbVie

11.6.1 AbbVie Company Information

11.6.2 AbbVie Overview

11.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 AbbVie Recent Developments

11.7 Youdim

11.7.1 Youdim Company Information

11.7.2 Youdim Overview

11.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Youdim Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Youdim Recent Developments

11.8 Delpor

11.8.1 Delpor Company Information

11.8.2 Delpor Overview

11.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Delpor Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Delpor Recent Developments

11.9 Lundbeck

11.9.1 Lundbeck Company Information

11.9.2 Lundbeck Overview

11.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Lundbeck Recent Developments

11.10 Intra-Cellular Therapies

11.10.1 Intra-Cellular Therapies Company Information

11.10.2 Intra-Cellular Therapies Overview

11.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Intra-Cellular Therapies Recent Developments

11.11 Novartis Pharmaceuticals Corporation

11.11.1 Novartis Pharmaceuticals Corporation Company Information

11.11.2 Novartis Pharmaceuticals Corporation Overview

11.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Novartis Pharmaceuticals Corporation Recent Developments

11.12 Noven Pharmaceuticals

11.12.1 Noven Pharmaceuticals Company Information

11.12.2 Noven Pharmaceuticals Overview

11.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Noven Pharmaceuticals Recent Developments

11.13 Otsuka

11.13.1 Otsuka Company Information

11.13.2 Otsuka Overview

11.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Otsuka Recent Developments

11.14 Pfizer

11.14.1 Pfizer Company Information

11.14.2 Pfizer Overview

11.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Pfizer Recent Developments

11.15 Reviva Pharmaceuticals

11.15.1 Reviva Pharmaceuticals Company Information

11.15.2 Reviva Pharmaceuticals Overview

11.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Reviva Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Bipolar Disorder Therapeutics Drugs Industry Chain Analysis

12.2 Bipolar Disorder Therapeutics Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Bipolar Disorder Therapeutics Drugs Production Mode & Process

12.4 Bipolar Disorder Therapeutics Drugs Sales and Marketing

12.4.1 Bipolar Disorder Therapeutics Drugs Sales Channels

12.4.2 Bipolar Disorder Therapeutics Drugs Distributors

12.5 Bipolar Disorder Therapeutics Drugs Customers

13 Market Dynamics

13.1 Bipolar Disorder Therapeutics Drugs Industry Trends

13.2 Bipolar Disorder Therapeutics Drugs Market Drivers

13.3 Bipolar Disorder Therapeutics Drugs Market Challenges

13.4 Bipolar Disorder Therapeutics Drugs Market Restraints

14 Key Findings in The Global Bipolar Disorder Therapeutics Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Allergan plc

Bristol–Myers Squibb

GSK

Janssen

AbbVie

Youdim

Delpor

Lundbeck

Intra-Cellular Therapies

Novartis Pharmaceuticals Corporation

Noven Pharmaceuticals

Otsuka

Pfizer Inc

Reviva Pharmaceuticals

List of Tables

Table 1. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Olanzapine (Zyprexa)

Table 3. Major Manufacturers of Quetiapine (Seroquel)

Table 4. Major Manufacturers of Risperidone (Risperdal)

Table 5. Major Manufacturers of Ariprazole (Abilify)

Table 6. Major Manufacturers of Ziprasidone (Geodon)

Table 7. Major Manufacturers of Clozapine (Clozaril)

Table 8. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Bipolar Disorder Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 11. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 12. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2019-2024)

Table 13. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2025-2030)

Table 14. Global Bipolar Disorder Therapeutics Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 15. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2019-2024) & (Units)

Table 16. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2025-2030) & (Units)

Table 17. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2019-2024)

Table 18. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2025-2030)

Table 19. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers (2019-2024) & (Units)

Table 20. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers (2019-2024)

Table 21. Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 22. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2019-2024)

Table 23. Global Key Players of Bipolar Disorder Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 24. Bipolar Disorder Therapeutics Drugs Price by Manufacturers 2019-2024 (USD/Unit)

Table 25. Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 26. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2023)

Table 27. Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Manufacturing Base Distribution and Headquarters

Table 28. Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Product Offered and Application

Table 29. Global Key Manufacturers of Bipolar Disorder Therapeutics Drugs, Date of Enter into This Industry

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 32. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 33. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2019-2024)

Table 34. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2025-2030)

Table 35. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 36. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 37. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2019-2024)

Table 38. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2025-2030)

Table 39. Bipolar Disorder Therapeutics Drugs Price by Type (2019-2024) & (USD/Unit)

Table 40. Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2025-2030) & (USD/Unit)

Table 41. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 42. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 43. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2019-2024)

Table 44. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2025-2030)

Table 45. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 46. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 47. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2019-2024)

Table 48. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2025-2030)

Table 49. Bipolar Disorder Therapeutics Drugs Price by Application (2019-2024) & (USD/Unit)

Table 50. Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2025-2030) & (USD/Unit)

Table 51. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 52. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 53. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 54. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 55. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 56. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 57. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 58. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 59. US & Canada Bipolar Disorder Therapeutics Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 60. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 61. US & Canada Bipolar Disorder Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 62. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2024) & (Units)

Table 63. US & Canada Bipolar Disorder Therapeutics Drugs Sales by Country (2025-2030) & (Units)

Table 64. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 65. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 66. Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 67. Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 68. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 69. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 70. Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 71. Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 72. Europe Bipolar Disorder Therapeutics Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 73. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 74. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 75. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2024) & (Units)

Table 76. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2025-2030) & (Units)

Table 77. China Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 78. China Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 79. China Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 80. China Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 81. China Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 82. China Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 83. China Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 84. China Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 85. Asia Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 86. Asia Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 87. Asia Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 88. Asia Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 89. Asia Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 90. Asia Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 91. Asia Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 92. Asia Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 93. Asia Bipolar Disorder Therapeutics Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 94. Asia Bipolar Disorder Therapeutics Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 95. Asia Bipolar Disorder Therapeutics Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 96. Asia Bipolar Disorder Therapeutics Drugs Sales by Region (2019-2024) & (Units)

Table 97. Asia Bipolar Disorder Therapeutics Drugs Sales by Region (2025-2030) & (Units)

Table 98. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2019-2024) & (Units)

Table 99. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2025-2030) & (Units)

Table 100. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2019-2024) & (Units)

Table 103. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2025-2030) & (Units)

Table 104. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 107. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 108. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 109. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2019-2024) & (Units)

Table 110. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2025-2030) & (Units)

Table 111. AstraZeneca Company Information

Table 112. AstraZeneca Description and Major Businesses

Table 113. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 114. AstraZeneca Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. AstraZeneca Recent Developments

Table 116. Allergan Company Information

Table 117. Allergan Description and Major Businesses

Table 118. Allergan Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 119. Allergan Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Allergan Recent Developments

Table 121. Bristol-Myers Squibb Company Information

Table 122. Bristol-Myers Squibb Description and Major Businesses

Table 123. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 124. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Bristol-Myers Squibb Recent Developments

Table 126. GSK Company Information

Table 127. GSK Description and Major Businesses

Table 128. GSK Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 129. GSK Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. GSK Recent Developments

Table 131. Janssen Company Information

Table 132. Janssen Description and Major Businesses

Table 133. Janssen Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 134. Janssen Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Janssen Recent Developments

Table 136. AbbVie Company Information

Table 137. AbbVie Description and Major Businesses

Table 138. AbbVie Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 139. AbbVie Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. AbbVie Recent Developments

Table 141. Youdim Company Information

Table 142. Youdim Description and Major Businesses

Table 143. Youdim Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 144. Youdim Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. Youdim Recent Developments

Table 146. Delpor Company Information

Table 147. Delpor Description and Major Businesses

Table 148. Delpor Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 149. Delpor Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Delpor Recent Developments

Table 151. Lundbeck Company Information

Table 152. Lundbeck Description and Major Businesses

Table 153. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 154. Lundbeck Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. Lundbeck Recent Developments

Table 156. Intra-Cellular Therapies Company Information

Table 157. Intra-Cellular Therapies Description and Major Businesses

Table 158. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 159. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 160. Intra-Cellular Therapies Recent Developments

Table 161. Novartis Pharmaceuticals Corporation Company Information

Table 162. Novartis Pharmaceuticals Corporation Description and Major Businesses

Table 163. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 164. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 165. Novartis Pharmaceuticals Corporation Recent Developments

Table 166. Noven Pharmaceuticals Company Information

Table 167. Noven Pharmaceuticals Description and Major Businesses

Table 168. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 169. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 170. Noven Pharmaceuticals Recent Developments

Table 171. Otsuka Company Information

Table 172. Otsuka Description and Major Businesses

Table 173. Otsuka Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 174. Otsuka Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 175. Otsuka Recent Developments

Table 176. Pfizer Company Information

Table 177. Pfizer Description and Major Businesses

Table 178. Pfizer Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 179. Pfizer Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 180. Pfizer Recent Developments

Table 181. Reviva Pharmaceuticals Company Information

Table 182. Reviva Pharmaceuticals Description and Major Businesses

Table 183. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 184. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 185. Reviva Pharmaceuticals Recent Developments

Table 186. Key Raw Materials Lists

Table 187. Raw Materials Key Suppliers Lists

Table 188. Bipolar Disorder Therapeutics Drugs Distributors List

Table 189. Bipolar Disorder Therapeutics Drugs Customers List

Table 190. Bipolar Disorder Therapeutics Drugs Market Trends

Table 191. Bipolar Disorder Therapeutics Drugs Market Drivers

Table 192. Bipolar Disorder Therapeutics Drugs Market Challenges

Table 193. Bipolar Disorder Therapeutics Drugs Market Restraints

Table 194. Research Programs/Design for This Report

Table 195. Key Data Information from Secondary Sources

Table 196. Key Data Information from Primary Sources

List of Figures

Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture

Figure 2. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Bipolar Disorder Therapeutics Drugs Market Share by Type in 2023 & 2030

Figure 4. Olanzapine (Zyprexa) Product Picture

Figure 5. Quetiapine (Seroquel) Product Picture

Figure 6. Risperidone (Risperdal) Product Picture

Figure 7. Ariprazole (Abilify) Product Picture

Figure 8. Ziprasidone (Geodon) Product Picture

Figure 9. Clozapine (Clozaril) Product Picture

Figure 10. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2023 & 2030

Figure 12. lumateperone

Figure 13. Central Nervous System (CNS) Disorders

Figure 14. Bipolar Disorder Therapeutics Drugs Report Years Considered

Figure 15. Global Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Bipolar Disorder Therapeutics Drugs Revenue 2019-2030 (US$ Million)

Figure 17. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2019-2030)

Figure 19. Global Bipolar Disorder Therapeutics Drugs Sales 2019-2030 ((Units)

Figure 20. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Bipolar Disorder Therapeutics Drugs Sales YoY (2019-2030) & (Units)

Figure 22. US & Canada Bipolar Disorder Therapeutics Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Bipolar Disorder Therapeutics Drugs Sales YoY (2019-2030) & (Units)

Figure 24. Europe Bipolar Disorder Therapeutics Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Bipolar Disorder Therapeutics Drugs Sales YoY (2019-2030) & (Units)

Figure 26. China Bipolar Disorder Therapeutics Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Bipolar Disorder Therapeutics Drugs Sales YoY (2019-2030) & (Units)

Figure 28. Asia (excluding China) Bipolar Disorder Therapeutics Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales YoY (2019-2030) & (Units)

Figure 30. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Bipolar Disorder Therapeutics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Bipolar Disorder Therapeutics Drugs in the World: Market Share by Bipolar Disorder Therapeutics Drugs Revenue in 2023

Figure 33. Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 35. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 36. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 37. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2019-2030)

Figure 43. US & Canada Bipolar Disorder Therapeutics Drugs Sales Share by Country (2019-2030)

Figure 44. U.S. Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 47. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 48. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 49. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 50. Europe Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2019-2030)

Figure 51. Europe Bipolar Disorder Therapeutics Drugs Sales Share by Country (2019-2030)

Figure 52. Germany Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. France Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 58. China Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 59. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 60. China Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 61. Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 62. Asia Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 63. Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 64. Asia Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 65. Asia Bipolar Disorder Therapeutics Drugs Revenue Share by Region (2019-2030)

Figure 66. Asia Bipolar Disorder Therapeutics Drugs Sales Share by Region (2019-2030)

Figure 67. Japan Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. India Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Bipolar Disorder Therapeutics Drugs Sales Share by Country (2019-2030)

Figure 78. Brazil Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Bipolar Disorder Therapeutics Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Bipolar Disorder Therapeutics Drugs Value Chain

Figure 84. Bipolar Disorder Therapeutics Drugs Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bipolar Disorders and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bipolar Disorder Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bipolar Disorder Drugs and Treatment Market Research Report 2025

Global Mood Stabilizers Market Research Report 2024

Mood Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bipolar Disorder Drug Treatment Market Research Report 2024

Global Bipolar Disorder Treatment Market Research Report 2024

Mental Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antidepressants Drugs Market Insights Forecast to 2030

Anti depressant Drugs Market

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global Mental Health Medications Market Research Report 2025

Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polycystic Ovarian Syndrome PCOS Therapeutics Market Insights Forecast to 2030

Global Seasonal Affective Disorder Drugs Market Research Report 2024

Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2024

Global Medical Lithium Carbonate Market Research Report 2024

Global Major Depressive Disorder Drug Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions